Edition:
United States

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

629.00SEK
6:38am EST
Change (% chg)

4.00kr (+0.64%)
Prev Close
625.00kr
Open
625.00kr
Day's High
634.00kr
Day's Low
617.00kr
Volume
3,914
Avg. Vol
28,952
52-wk High
717.00kr
52-wk Low
355.00kr

Chart for

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.69
Market Cap(Mil.): kr13,568.82
Shares Outstanding(Mil.): 21.71
Dividend: 2.60
Yield (%): 0.42

Financials

  Industry Sector
P/E (TTM): -- 60.10 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 34.69
ROE: -- 19.86 15.46

BRIEF-William Demant fund raises stake in Vitrolife to 21.6 pct

* William Demants Og Hustru Ida Emilies Fond​ (Oticon fund) raises stake in Vitrolife AB to 21.6 percent

Nov 10 2017

BRIEF-Vitrolife Q3 core profit rises, like-for-like sales grow 20 pct​

* Q3 ‍sales amounted to SEK 246 (210) million, corresponding to an increase of 17 percent in SEK​

Nov 02 2017

BRIEF-Vitrolife Q2 EBITDA rises to SEK 112 mln

* Q2 operating income before depreciation and amortisation (EBITDA) amounted to SEK 112 (74) million

Jul 14 2017

Earnings vs. Estimates